ANTIINFLAMMATORY 17-BETA-THIOALKYL-16-ALPHA,17-ALPHA-KETAL AND 17-BETA-THIOALKYL-16-ALPHA,17-ALPHA-ACETAL ANDROSTANES - A NEW CLASS OF AIRWAY SELECTIVE STEROIDS FOR THE TREATMENT OF ASTHMA
Mj. Ashton et al., ANTIINFLAMMATORY 17-BETA-THIOALKYL-16-ALPHA,17-ALPHA-KETAL AND 17-BETA-THIOALKYL-16-ALPHA,17-ALPHA-ACETAL ANDROSTANES - A NEW CLASS OF AIRWAY SELECTIVE STEROIDS FOR THE TREATMENT OF ASTHMA, Journal of medicinal chemistry, 39(25), 1996, pp. 4888-4896
The synthesis and anti-inflammatory potencies of a new class of 17 bet
a-tkioalkyl-16 alpha,17 alpha-ketal and -acetal androstanes are descri
bed. This new class of steroids was made by fragmentation of 2-thioxo-
1,2-dihydropyrid-1-yl esters of the corresponding 17-acids to the 17-r
adical. The radical generated was trapped using a variety of radicophi
lic disulfides, giving a steroidal D-ring having acetal or ketal funct
ionality at C-16 and C-17, together with a sulfide link at C-17. Compo
unds from this series bind to the glucocorticoid receptor with high po
tency and are functional agonists as measured by their ability to indu
ce tyrosine aminotransferase activity in a rat hepatic cell line in vi
tro. These 17 beta-thioalkyl androstanes potently inhibit Sephadex-ind
uced rat lung inflammation when administered directly into the airways
. The high topical potency, together with a low propensity to induce s
ystemic glucocorticoid-like side effects (rat thymus involution), prov
ides the present compounds with a high degree of airway selectivity co
mpared with currently available inhaled glucocorticoids. The presently
described 17 beta-thioalkyl-16 alpha,17 alpha-ketal androstanes may b
e useful for therapies for inflammatory diseases such as asthma.